Meeting
2014 ASCO Annual Meeting
Treatment patterns, mortality, and costs of care in unfit patients (pts) with relapsed chronic lymphocytic leukemia (CLL).
Authors
Helen Varker
Truven Health Analytics, Inc., Cambridge, MA
Helen Varker , Xue Song , Nicole Meyer , Stephanie A. Gregory , Javier Pinilla-Ibarz , Scott David Ramsey
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Leukemia, Myelodysplasia, and Transplantation
Track
Hematologic Malignancies—Leukemia, Myelodysplastic Syndromes, and Allotransplant
Sub Track
Leukemia
Citation
J Clin Oncol 32:5s, 2014 (suppl; abstr 7105)
DOI
10.1200/jco.2014.32.15_suppl.7105
Abstract #
7105
Poster Bd #
390
Abstract Disclosures
Similar Posters
Poster
2016 ASCO Quality Care Symposium
Real-world treatment patterns and health care resource utilization (HRU) among patients with chronic lymphocytic leukemia (CLL) by regimen.
First Author: Brad Schenkel
Poster
2014 ASCO Annual Meeting
Inotuzumab ozogamicin (IO) in combination with low-intensity chemotherapy as front-line therapy for older patients (pts) and as salvage therapy for adult with R/R acute lymphoblastic leukemia (ALL).
First Author: Elias Jabbour
Poster
2017 ASCO Annual Meeting
Updated results of a phase I/II study of inotuzumab ozogamicin in combination with low-intensity chemotherapy (mini-hyper-CVD) as frontline therapy for older patients with acute lymphoblastic leukemia.
First Author: Nicholas James Short
Poster
2017 ASCO Annual Meeting
Allogeneic hematopoietic cell transplantation for myelofibrosis (MF) in high risk patients.
First Author: Swapna Narayana